On behalf of Viroscience diagnostic laboratory at the Erasmus MC, Rotterdam, we welcome the proposed amendments to the In Vitro Diagnostic Medical Devices Regulation (IVDR) and strongly support their incorporation into the revised regulatory framework. The proposed changes will improve the flexibility, sustainability, and resilience of diagnostic services across the European Union.
ErasmusMC
Academic / research · Netherlands
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track ErasmusMC in PolicySpeak: request access →
Work at ErasmusMC? so we know who speaks for it.
Their record over time
ErasmusMC filed 2 positions between 1 Oct 2025 and 21 Jul 2026, across 1 of the 326 legislative files tracked here.
What they argued
I'm representing the Dutch IVDR taskforce in which representatives of medical diagnostic laboratories working in the field of clinical chemistry, immunology, microbiology, pathology, genetics and pharmacy work together to advise diagnostic laboratories in the Netherlands on how to implement IVDR for laboratory-developed tests.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from ErasmusMC’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.